在肝细胞癌中CMSS1的预后价值和基因调节网络

Cheng Chen1,1, Caiming Wang2,1, Wei Liu3,1

  • 1Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.

概括

在肝肝细胞癌 (LIHC) 中,Cms1核糖体小子单元同源 (CMSS1) 的上调,与晚期瘤和较差的存活率相关. 这表明CMSS1是LIHC的潜在诊断和预后标志物.